Literature DB >> 21779674

The genetic and molecular basis of congenital cataract.

Alessandro Santana1, Mauro Waiswo.   

Abstract

Congenital cataracts are one of the most treatable causes of visual impairment and blindness during infancy, with an estimated prevalence of 1 to 6 cases per 10,000 live births. Approximately fifty percent of all congenital cataract cases may have a genetic cause. All three types of Mendelian inheritance have been reported for cataract; however, autosomal dominant transmission seems to be the most frequent. The transparency and high refractive index of the lens are achieved by the precise architecture of the fiber cells and the homeostasis of the lens proteins in terms of their concentration, stability, and supramolecular organization. Research on hereditary congenital cataract led to the identification of several classes of candidate genes that encode proteins such crystallins, lens specific connexins, aquaporine, cytoskeletal structural proteins, and developmental regulators. The purpose of this study was to review the literature on the recent advances made in understanding the molecular genetic basis of congenital cataracts.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21779674     DOI: 10.1590/s0004-27492011000200016

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  35 in total

1.  Use of high-throughput targeted exome sequencing in genetic diagnosis of Chinese family with congenital cataract.

Authors:  Ming-Fu Ma; Lian-Bing Li; Yun-Qi Pei; Zhi Cheng
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

2.  Novel mutations in CRYBB1/CRYBB2 identified by targeted exome sequencing in Chinese families with congenital cataract.

Authors:  Peng Chen; Hao Chen; Xiao-Jing Pan; Su-Zhen Tang; Yu-Jun Xia; Hui Zhang
Journal:  Int J Ophthalmol       Date:  2018-10-18       Impact factor: 1.779

3.  A novel Cx50 (GJA8) p.H277Y mutation associated with autosomal dominant congenital cataract identified with targeted next-generation sequencing.

Authors:  Chong Chen; Qiao Sun; Mingmin Gu; Kun Liu; Yong Sun; Xun Xu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-07       Impact factor: 3.117

4.  Lens density tracking in mice by Scheimpflug imaging.

Authors:  Oliver Puk; Martin Hrabĕ de Angelis; Jochen Graw
Journal:  Mamm Genome       Date:  2013-08-09       Impact factor: 2.957

5.  A novel mutation of p.F32I in GJA8 in human dominant congenital cataracts.

Authors:  Feng-Tao Dang; Fa-Yu Yang; Ye-Qin Yang; Xiang-Lian Ge; Ding Chen; Liu Zhang; Xin-Ping Yu; Feng Gu; Yi-Hua Zhu
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

6.  Exome sequencing identifies a novel mutation in GJA8 associated with inherited cataract in a Chinese family.

Authors:  Mei Ren; Xin Guang Yang; Xiao Jie Dang; Jin An Xiao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-26       Impact factor: 3.117

7.  A crystallin gene network in the mouse retina.

Authors:  Justin P Templeton; XiangDi Wang; Natalie E Freeman; Zhiwei Ma; Anna Lu; Fielding Hejtmancik; Eldon E Geisert
Journal:  Exp Eye Res       Date:  2013-08-24       Impact factor: 3.467

Review 8.  Screening, genetics, risk factors, and treatment of neonatal cataracts.

Authors:  Jinyu Li; Chun-Hong Xia; Eddie Wang; Ke Yao; Xiaohua Gong
Journal:  Birth Defects Res       Date:  2017-05-22       Impact factor: 2.661

9.  A novel T→G splice site mutation of CRYBA1/A3 associated with autosomal dominant nuclear cataracts in a Chinese family.

Authors:  Zhenfei Yang; Dongmei Su; Qian Li; Fan Yang; Zicheng Ma; Siquan Zhu; Xu Ma
Journal:  Mol Vis       Date:  2012-05-15       Impact factor: 2.367

10.  A cataract-causing connexin 50 mutant is mislocalized to the ER due to loss of the fourth transmembrane domain and cytoplasmic domain.

Authors:  Madhavi Latha Somaraju Chalasani; Madhavi Muppirala; Surya Prakash G Ponnam; Chitra Kannabiran; Ghanshyam Swarup
Journal:  FEBS Open Bio       Date:  2012-11-27       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.